VEGFR2/KDR Monoklonaler Antikörper
VEGFR2/KDR Monoklonal Antikörper für WB, ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
human
Anwendung
WB, ELISA
Konjugation
Unkonjugiert
CloneNo.
1G2A8
Kat-Nr. : 67407-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
67407-1-PBS bindet in WB, ELISA VEGFR2/KDR und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Maus / IgG1 |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | VEGFR2/KDR fusion protein Ag24589 |
| Vollständiger Name | kinase insert domain receptor (a type III receptor tyrosine kinase) |
| Berechnetes Molekulargewicht | 1356 aa, 152 kDa |
| Beobachtetes Molekulargewicht | 230 kDa |
| GenBank-Zugangsnummer | BC131822 |
| Gene symbol | KDR |
| Gene ID (NCBI) | 3791 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-G-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
KDR, also named as VEGFR-2, FLK1 and CD309, is a receptor for VEGF or VEGFC. KDR which belongs to the protein kinase superfamily, has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. KDR functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. Mutations of this gene are implicated in infantile capillary hemangiomas.

